New Dietary Guidelines Will Recommend Americans 'Eat Whole Food,' Says RFK Jr.
The Department of Health and Human Services and the U.S. Department of Agriculture (USDA) are working on a new set of guidelines that will be in place through 2030.
'We are about to reissue the dietary guidelines, and we're going to do it very quickly. We have until January, but … I think we'll have it done even before August,' Kennedy said in Washington while testifying to a House of Representatives committee.
The current dietary guidelines, published in December 2020, run 164 pages. They say that people should eat a healthy diet and limit sugary foods and drinks.
Health and agriculture officials in late 2024 received a draft of updated guidelines from an advisory committee that spans 421 pages and proposed instructing Americans to eat less meat, avoid full-fat dairy products, and ingest more plant-based proteins such as lentils.
Kennedy said on Wednesday that the 2024 update was 'clearly written by industry' and driven by the 'kind of carnal impulses that put Froot Loops at the top of the food pyramid.' In the past, some members of the advisory committee have been found to have links to corporations, including Kellogg.
Kennedy told lawmakers: 'We are changing that. So we're going to have four-page dietary guidelines that tell people essentially, 'eat whole food, eat the food that's good for you.''
The purpose of the guidelines is to outline what Americans should eat and drink to get enough nutrients, stay healthy, and prevent disease, according to the government. The guidelines are updated every four years and are 'written for a professional audience, including policymakers, healthcare providers, nutrition educators, and Federal nutrition program operators.'
Click here to read more…
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Gulf Insider
3 days ago
- Gulf Insider
RFK Jr. Drops Stunning New Vaccine Announcement
HHS Secretary Robert F. Kennedy Jr. just took aim at a system that has failed Americans for nearly 40 years, the Vaccine Injury Compensation Program (VICP). This program was created under the 1986 National Childhood Vaccine Injury Act, which shielded vaccine manufacturers from lawsuits over injury claims. Before becoming HHS Secretary, Kennedy exposed how vaccine manufacturers were being hammered with lawsuits due to injuries. One of the largest manufacturers at the time, Wyeth (now part of Pfizer), reportedly told President Reagan: give us legal protection or we'll stop making vaccines. Reagan's response? Why not just make safer vaccines? Wyeth's answer: Vaccines are 'unavoidably unsafe.' That phrase— ' unavoidably unsafe ' —would later appear in a Supreme Court decision and reflects the legal premise that some vaccine injuries are inevitable. 'And so, anybody who tells you vaccines are safe and effective, the industry itself got immunity from liability by convincing the President and Congress that vaccines are unavoidably unsafe,' Kennedy previously stated. Before becoming HHS Secretary, Kennedy exposed how vaccine manufacturers were being hammered with lawsuits due to of the largest manufacturers at the time, Wyeth (now part of Pfizer), reportedly told President Reagan: give us legal protection or we'll stop making… — The Vigilant Fox 🦊 (@VigilantFox) July 28, 2025 Senator Edward Kennedy, a key sponsor of the law, wrote at the time: 'When … children are the victims of an appropriate and rational national policy, a compassionate government will assist them in their hour of need.' That compassionate government never showed up. Over 39 years, the VICP has awarded just $5.4 billion to 12,000 victims. That comes out to about '1.2 awards per million doses administered.' In a brand-new statement on X, Secretary Kennedy said he intends to FIX the broken system. He explained that the court was meant to resolve claims 'quickly and fairly,' with 'doubts about causation resolved in favor of the victim.' But that hasn't happened. 'The structure itself hobbles claimants,' Kennedy wrote. 'The defendant is HHS, not the vaccine makers; and claimants are therefore facing the monumental power and bottomless pockets of the U.S. government represented by the Department of Justice.' He explained how Special Masters, who decide the cases, often come from government or political backgrounds and typically show a strong pro-government bias. 'There is no discovery, and the rules of evidence do not apply,' Kennedy lamented. He added that petitioners' attorneys report retaliation, fee suppression, and even denied access to the Vaccine Safety Datalink, a taxpayer-funded CDC database containing the best data on vaccine injuries. Worse, expert witnesses for injured children have reported intimidation and threats to their careers, including the loss of NIH funding if they testify. But Kennedy says that era is over. 'The VICP is broken, and I intend to fix it,' he wrote on X. 'I will not allow the VICP to continue to ignore its mandate and fail its mission of quickly and fairly compensating vaccine-injured individuals.' Kennedy added that he is working closely with AG Pam Bondi and HHS staff to restore the court's original mission and pledges to 'steer the Vaccine Court back to its original Congressional intent.' Also read: Survey Reveals 'Seismic Shift' As More Parents Reject Vaccine Schedule
Daily Tribune
23-07-2025
- Daily Tribune
Eating Avocados Twice a Week Linked to Lower Risk of Heart Disease, New Study Finds
A recent study published in the Journal of the American Heart Association has found that eating at least two servings of avocado per week may significantly lower the risk of heart disease and stroke. Researchers believe this is the first large-scale, long-term study to show a strong connection between high avocado consumption and reduced risk of cardiovascular events such as coronary heart disease and stroke. Avocados are rich in dietary fiber and heart-healthy fats—especially monounsaturated fats—which are known to support cardiovascular health. Previous clinical trials have also shown that avocados can help reduce risk factors like high cholesterol. 'This is particularly noteworthy given how avocado consumption has increased sharply in the U.S. over the past 20 years,' said Dr. Lorena S. Pacheco, a nutrition expert at Harvard University. 'According to data from the U.S. Department of Agriculture, more people are making avocados a regular part of their diet.' The researchers followed over 68,000 women (ages 30–55) from the Nurses' Health Study and more than 41,000 men (ages 40–75) from the Health Professionals Follow-Up Study for over 30 years. All participants were free of cancer, coronary heart disease, and stroke at the start of the study. During the study, the team documented 9,185 cases of coronary heart disease and 5,290 strokes. Participants filled out food frequency questionnaires at the beginning of the study and every four years after that. Avocado intake was measured by asking how often and how much they consumed. One serving was defined as half an avocado or half a cup of avocado. The results showed that those who ate two or more servings per week had a significantly lower risk of heart-related illnesses compared to those who rarely or never ate avocados.
Gulf Insider
22-07-2025
- Gulf Insider
What To Know About Big Pharma, In Charts
Prescription drugs provide relief from pain, fight infection, stabilize moods, reduce inflammation, combat dread diseases, and extend lives. These medications have become a fact of life for many—perhaps most—Americans. On average, half of them took at least one prescription drug in a given month, according to a recent CDC survey. More than 13 percent took five or more. And the rate is growing. In 2020 Americans filled 6.4 billion prescriptions, about 19 per person. By 2023, Americans were consuming more than 210 billion daily doses of medication annually. That's more than 600 pills, shots, drops, IVs, creams, mists, or suppositories for every person in the country. A child born in 2019 in the United States can expect to spend roughly half of his or her life taking prescription medications, according to Jessica Y. Ho, a researcher at Pennsylvania State University. The United States consumes more prescription drugs than any country in the world and spends nearly twice as much for them as all other nations combined. Global pharmaceutical sales were estimated at $1.6 trillion in 2023, according to Statista. That's roughly equal to the gross domestic product of Spain and nearly double that of Switzerland. The ten largest pharmaceutical companies in the United States alone have a combined worth of more than $2.1 trillion. Recent growth in the industry has been driven by the creation of new types of medications including biologics and peptides. These medications can be highly effective but also very expensive. Biologics are drugs derived from living sources rather than chemicals. Medicare paid nearly $66,000 per patient for prescriptions of Humira in 2023. That's a biologic medication to treat rheumatoid arthritis, plaque psoriasis, and other diseases. Development of biologics has more than tripled over the last decade. The Food and Drug Administration (FDA) approved 17 biologics in 2023, up from an average of 4 per year between 1999 and 2013. Americans consumed 72 percent of the top 50 biologic drugs sold in the world in 2022, according to the Department of Health and Human Services. Peptides are drugs that mimic the function of certain substances within the human body. A particular type of peptide called GLP-1 helps regulate blood sugar and appetite. Ozempic, Weygovy, and Trulicity are GLP-1 medications. Medicare Part D alone paid more than $22 billion to provide GLP-1 medications in 2023, an increase of nearly 130 percent in two years. Currently, the GLP-1 market is dominated by Novo Nordisk, Eli Lilly, AstraZeneca, and Sanofi, though others are working to develop similar medications. U.S. drug prices were more than double those in other countries as of 2022, and more than 4 times as much for brand-name drugs, according to global consulting firm RAND. Pharmaceutical companies do considerable business with the federal government, deriving $387 billion in payments from Medicare Part D and Medicaid in 2023 alone. Pharmaceutical companies and some 100 allied political action committees spent more than $15 million in campaign contributions during each of the last two presidential elections, and nearly as much during the mid-terms. Those amounts are overshadowed by the pharmaceutical industry's annual lobbying expenditures. The industry spent more than $150 million to influence federal and state legislatures in 2024. Of its more than 700 lobbyists, nearly two thirds were former government employees. The pharmaceutical lobby spent more money over the past quarter century than did electric utilities, oil and gas companies, hospitals and nursing homes—more than the automotive and defense aerospace industries combined. Research Developing new medications is expensive. The average cost of bringing a new drug market can range up to $2 billion, according to data cited by the Congressional Budget Office. Congress aided companies investing in research via the One Big Beautiful Bill Act, which includes a provision for makers of drugs that treat rare diseases. The law widens the definition of a rare disease drug and further delays Medicare price negotiations on drugs that treat them. That allows the makers of those drugs to continue charging Medicare full price for the medications, in order to fund future research. Normally, a drug that has been marketed for at least 9 years and receives $200 million per year in Medicare payments would be eligible for price negotiation.
